Stocktoria
Sarepta Therapeutics, Inc. SRPT
Sarepta Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 10,324,404 | $1.6B | 9.84% |
| AQR CAPITAL MANAGEMENT LLC | 6,433,112 | $138.6M | 6.13% |
| TWO SIGMA INVESTMENTS, LP | 4,593,195 | $99.9M | 4.38% |
| CITADEL ADVISORS LLC | 2,281,469 | $49.6M | 2.17% |
| RENAISSANCE TECHNOLOGIES LLC | 1,665,078 | $36.2M | 1.59% |
| MILLENNIUM MANAGEMENT LLC | 1,221,682 | $26.6M | 1.16% |
| D. E. Shaw & Co., Inc. | 601,786 | $13.1M | 0.57% |
| Bridgewater Associates, LP | 134,277 | $2.9M | 0.13% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.